CRANBURY, N.J., April 16, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics, Inc. (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced the appointment of William D. “Chip” Baird, III as Chief Financial Officer, effective today. Mr. Baird brings over 15 years of experience in finance and strategic planning to Amicus, where he will be responsible for all Finance, Accounting and Investor Relations activities. Mr. Baird will report directly to John F. Crowley, Chairman and Chief Executive Officer.
